On the public citation graph
Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers
0 signed · 365 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2014.14601openalex-snapshot
Molecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing
inferredcites →https://doi.org/10.1001/jama.2014.14604openalex-snapshot
Clinical Exome Sequencing for Genetic Identification of Rare Mendelian Disorders
inferredcites →https://doi.org/10.1001/jama.2014.1717openalex-snapshot
Clinical Interpretation and Implications of Whole-Genome Sequencing
inferredcites →https://doi.org/10.1002/0471250953.bi0113s39openalex-snapshot
The Human Gene Mutation Database (HGMD) and Its Exploitation in the Fields of Personalized Genomics and Molecular Evolution
inferredcites →https://doi.org/10.1002/ajmg.a.35942openalex-snapshot
Practices and Policies of Clinical Exome Sequencing Providers: Analysis and Implications
inferredcites →https://doi.org/10.1002/humu.22347openalex-snapshot
PhenoTips: Patient Phenotyping Software for Clinical and Research Use
inferredcites →https://doi.org/10.1007/s00439-015-1535-8openalex-snapshot
Exome sequencing unravels unexpected differential diagnoses in individuals with the tentative diagnosis of Coffin–Siris and Nicolaides–Baraitser syndromes
inferredcites →https://doi.org/10.1016/j.ajhg.2012.06.008openalex-snapshot
De Novo Mutations in MLL Cause Wiedemann-Steiner Syndrome
inferredcites →https://doi.org/10.1016/j.ajhg.2013.05.019openalex-snapshot
PIK3R1 Mutations Cause Syndromic Insulin Resistance with Lipoatrophy
inferredcites →https://doi.org/10.1016/j.ajhg.2014.03.013openalex-snapshot
Mutations Affecting the SAND Domain of DEAF1 Cause Intellectual Disability with Severe Speech Impairment and Behavioral Problems
inferredcites →https://doi.org/10.1016/j.ajhg.2015.06.009openalex-snapshot
The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities
inferredcites →https://doi.org/10.1016/s0140-6736(12)61480-9openalex-snapshot
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study
inferredcites →https://doi.org/10.1038/gim.2014.58openalex-snapshot
The usefulness of whole-exome sequencing in routine clinical practice
inferredcites →https://doi.org/10.1038/gim.2015.148openalex-snapshot
Clinical application of whole-exome sequencing across clinical indications
inferredcites →https://doi.org/10.1038/gim.2015.30openalex-snapshot
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
inferredcites →https://doi.org/10.1038/nature13772openalex-snapshot
Synaptic, transcriptional and chromatin genes disrupted in autism
inferredcites →https://doi.org/10.1038/nature13908openalex-snapshot
The contribution of de novo coding mutations to autism spectrum disorder
inferredcites →https://doi.org/10.1038/nature15393openalex-snapshot
A global reference for human genetic variation
inferredcites →https://doi.org/10.1038/nature19057openalex-snapshot
Analysis of protein-coding genetic variation in 60,706 humans
inferredcites →https://doi.org/10.1038/ng.2933openalex-snapshot
Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling
inferredcites →https://doi.org/10.1038/ng.3410openalex-snapshot
Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families
inferredcites →https://doi.org/10.1038/ng.712openalex-snapshot
A de novo paradigm for mental retardation
inferredcites →https://doi.org/10.1038/ng.806openalex-snapshot
A framework for variation discovery and genotyping using next-generation DNA sequencing data
inferredcites →https://doi.org/10.1056/nejmoa1306555openalex-snapshot
Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders
inferredcites →https://doi.org/10.1093/bioinformatics/btm229openalex-snapshot
Manual curation is not sufficient for annotation of genomic databases
inferredcites →https://doi.org/10.1093/nar/gkq603openalex-snapshot
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
inferredcites →https://doi.org/10.1093/nar/gkt1026openalex-snapshot
The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data
inferredcites →https://doi.org/10.1093/nar/gku1205openalex-snapshot
OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders
inferredcites →https://doi.org/10.1155/2015/456479openalex-snapshot
A Comparison of Variant Calling Pipelines Using Genome in a Bottle as a Reference
inferredcites →https://doi.org/10.1186/gm543openalex-snapshot
Choice of transcripts and software has a large effect on variant annotation
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.14198openalex-snapshot
Clinician-Driven Reanalysis of Exome Sequencing Data From Patients With Inherited Retinal Diseases
inferred← citeshttps://doi.org/10.1002/ajh.24917openalex-snapshot
Utility and limitations of exome sequencing in the molecular diagnosis of pediatric inherited platelet disorders
inferred← citeshttps://doi.org/10.1002/ajmg.a.38298openalex-snapshot
Reanalyzing exomes may be worthwhile
inferred← citeshttps://doi.org/10.1002/ajmg.a.38483openalex-snapshot
New intellectual disability syndrome identified
inferred← citeshttps://doi.org/10.1002/ajmg.a.38542openalex-snapshot
Marked yield of re‐evaluating phenotype and exome/target sequencing data in 33 individuals with intellectual disabilities
inferred← citeshttps://doi.org/10.1002/ajmg.a.38636openalex-snapshot
Biallelic loss‐of‐function WNT5A mutations in an infant with severe and atypical manifestations of Robinow syndrome
inferred← citeshttps://doi.org/10.1002/ajmg.a.38838openalex-snapshot
Diagnostic clarity of exome sequencing following negative comprehensive panel testing in the neonatal intensive care unit
inferred← citeshttps://doi.org/10.1002/ajmg.a.61558openalex-snapshot
Limitations of exome sequencing in detecting rare and undiagnosed diseases
inferred← citeshttps://doi.org/10.1002/ajmg.a.63302openalex-snapshot
Retrospective identification of patients with SRRM2‐related neurodevelopmental disorder in a single tertiary children's hospital
inferred← citeshttps://doi.org/10.1002/ajmg.a.63392openalex-snapshot
Expansion of the phenotypic spectrum associated with pathogenic missense variation in DHX16
inferred← citeshttps://doi.org/10.1002/ajmg.a.63817openalex-snapshot
Utility of genome sequencing in exome‐negative pediatric patients with neurodevelopmental phenotypes
inferred← citeshttps://doi.org/10.1002/ajmg.c.31848openalex-snapshot
The odyssey of complex neurogenetic disorders: From undetermined to positive
inferred← citeshttps://doi.org/10.1002/humu.23339openalex-snapshot
Functional analysis of novelDEAF1variants identified through clinical exome sequencing expandsDEAF1-associated neurodevelopmental disorder (DAND) phenotype
inferred← citeshttps://doi.org/10.1002/humu.24347openalex-snapshot
Genome sequencing demonstrates high diagnostic yield in children with undiagnosed global developmental delay/intellectual disability: A prospective study
inferred← citeshttps://doi.org/10.1002/humu.24495openalex-snapshot
VariantAlert: A web‐based tool to notify updates in genetic variant annotations
inferred← citeshttps://doi.org/10.1002/jgc4.1119openalex-snapshot
A toolkit for genetics providers in follow‐up of patients with non‐diagnostic exome sequencing
inferred← citeshttps://doi.org/10.1002/jgc4.1161openalex-snapshot
Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing
inferred← citeshttps://doi.org/10.1002/jgc4.1968openalex-snapshot
The current landscape of clinical exome and genome reanalysis in the U.S.
inferred← citeshttps://doi.org/10.1002/jha2.1002openalex-snapshot
Certainty in uncertainty: Determining the rate and reasons for reclassification of variants of uncertain significance in haematological malignancies
inferred← citeshttps://doi.org/10.1002/jimd.12507openalex-snapshot
How to proceed after “negative” exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques
inferred← citeshttps://doi.org/10.1002/jimd.12663openalex-snapshot
Integrative omics approaches to advance rare disease diagnostics
inferred← citeshttps://doi.org/10.1002/jmd2.70028openalex-snapshot
HMG ‐ CoA Synthase‐2 Deficiency: Neonatal Hyperammonemic Coma and Abnormal Metabolic Screening Resembling Maple Syrup Urine Disease
inferred← citeshttps://doi.org/10.1002/lrh2.10385openalex-snapshot
Sync for Genes Phase 5: Computable artifacts for sharing dynamically annotated FHIR ‐formatted genomic variants
inferred← citeshttps://doi.org/10.1002/mgg3.1397openalex-snapshot
Missed diagnoses: Clinically relevant lessons learned through medical mysteries solved by the Undiagnosed Diseases Network
inferred← citeshttps://doi.org/10.1002/mgg3.1508openalex-snapshot
Evaluating systematic reanalysis of clinical genomic data in rare disease from single center experience and literature review
inferred← citeshttps://doi.org/10.1002/mgg3.355openalex-snapshot
Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness
inferred← citeshttps://doi.org/10.1002/mgg3.560openalex-snapshot
RNA‐Seq detects a SAMD12‐EXT1 fusion transcript and leads to the discovery of an EXT1 deletion in a child with multiple osteochondromas
inferred← citeshttps://doi.org/10.1002/path.5157openalex-snapshot
Ethical considerations for modern molecular pathology
inferred← citeshttps://doi.org/10.1002/pd.6886openalex-snapshot
Diagnostic Yield After Postnatal Reanalysis of Prenatal Exome Sequencing Results
inferred← citeshttps://doi.org/10.1007/978-1-4939-0727-4_19openalex-snapshot
Reporting Clinical Genomic Assay Results and the Role of the Pathologist
inferred← citeshttps://doi.org/10.1007/978-3-030-05517-2_3openalex-snapshot
Mitochondrial Disease Genetics
inferred← citeshttps://doi.org/10.1007/978-3-030-63449-0_3openalex-snapshot
Genetic Testing in Neuromuscular Diseases
inferred← citeshttps://doi.org/10.1007/978-3-030-70147-5_9openalex-snapshot
Molecular Genetics in the Next Generation Sequencing Era
inferred← citeshttps://doi.org/10.1007/978-3-319-96830-8_20openalex-snapshot
Reporting Clinical Genomic Assay Results and the Role of the Pathologist
inferred← citeshttps://doi.org/10.1007/s00415-023-11758-3openalex-snapshot
Ordering genetic testing by neurologists: points to consider
inferred← citeshttps://doi.org/10.1007/s00415-023-11991-wopenalex-snapshot
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease
inferred← citeshttps://doi.org/10.1007/s00415-024-12319-yopenalex-snapshot
Variants in mitochondrial disease genes are common causes of inherited peripheral neuropathies
inferred← citeshttps://doi.org/10.1007/s00431-023-05279-4openalex-snapshot
Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context
inferred← citeshttps://doi.org/10.1007/s00439-019-02021-9openalex-snapshot
Gene pathogenicity prediction of Mendelian diseases via the random forest algorithm
inferred← citeshttps://doi.org/10.1007/s00439-021-02343-7openalex-snapshot
NGS and phenotypic ontology-based approaches increase the diagnostic yield in syndromic retinal diseases
inferred← citeshttps://doi.org/10.1007/s00439-024-02664-3openalex-snapshot
Semiautomated approach focused on new genomic information results in time and effort-efficient reannotation of negative exome data
inferred← citeshttps://doi.org/10.1007/s10072-023-07210-zopenalex-snapshot
Utility of exome sequencing for the diagnosis of pediatric-onset neuromuscular diseases beyond diagnostic yield: a narrative review
inferred← citeshttps://doi.org/10.1007/s10545-017-0128-1openalex-snapshot
The role of the clinician in the multi‐omics era: are you ready?
inferred← citeshttps://doi.org/10.1007/s10689-020-00172-7openalex-snapshot
Genetic health professionals’ experiences with initiating reanalysis of genomic sequence data
inferred← citeshttps://doi.org/10.1007/s11673-023-10267-2openalex-snapshot
The Need to Standardize the Reanalysis of Genomic Sequencing Results: Findings from Interviews with Underserved Families in Genomic Research
inferred← citeshttps://doi.org/10.1007/s40291-020-00495-2openalex-snapshot
The Impact of Next-Generation Sequencing on the Diagnosis, Treatment, and Prevention of Hereditary Neuromuscular Disorders
inferred← citeshttps://doi.org/10.1007/s40291-021-00541-7openalex-snapshot
Clinical Exome Reanalysis: Current Practice and Beyond
inferred← citeshttps://doi.org/10.1007/s44162-026-00244-9openalex-snapshot
The role of genomics in contemporary nephrology and the imminent horizons of genomic reanalysis
inferred← citeshttps://doi.org/10.1016/b978-0-12-815923-1.00002-xopenalex-snapshot
Utility of the “omics” in kidney disease: Methods of analysis, sampling considerations, and technical approaches in renal biomarkers
inferred← citeshttps://doi.org/10.1016/b978-0-12-818872-9.00065-0openalex-snapshot
Diagnosis of genetic and metabolic conditions
inferred← citeshttps://doi.org/10.1016/b978-0-12-820029-2.00001-2openalex-snapshot
The history and evolving paradigm for genomic diagnosis of mitochondrial diseases
inferred← citeshttps://doi.org/10.1016/b978-0-323-62520-3.00006-3openalex-snapshot
Ambiguous Genitalia
inferred← citeshttps://doi.org/10.1016/b978-0-323-99209-1.00009-0openalex-snapshot
Approaches to diagnosis for individuals with a suspected inherited white matter disorder
inferred← citeshttps://doi.org/10.1016/b978-0-323-99417-0.00017-3openalex-snapshot
Muscle weakness (genetic muscle diseases)
inferred← citeshttps://doi.org/10.1016/b978-0-443-10944-7.00001-9openalex-snapshot
General Aspects of the Patient’s Neurologic History
inferred← citeshttps://doi.org/10.1016/bs.adgen.2026.06.003openalex-snapshot
Advances in the genetics of TCR inborn errors of immunity
inferred← citeshttps://doi.org/10.1016/bs.ctdb.2019.01.005openalex-snapshot
Translating genomics to the clinical diagnosis of disorders/differences of sex development
inferred← citeshttps://doi.org/10.1016/j.ajhg.2019.02.025openalex-snapshot
The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results
inferred← citeshttps://doi.org/10.1016/j.ajhg.2019.05.017openalex-snapshot
Analyzing and Reanalyzing the Genome: Findings from the MedSeq Project
inferred← citeshttps://doi.org/10.1016/j.anpede.2024.503712openalex-snapshot
Genetic counselling in the era of next generation sequencing
inferred← citeshttps://doi.org/10.1016/j.anpedi.2024.503712openalex-snapshot
Asesoramiento genético en la era de la secuenciación masiva
inferred← citeshttps://doi.org/10.1016/j.braindev.2023.05.006openalex-snapshot
Integrating whole-genome sequencing and transcriptomic findings in the diagnosis and management of Coffin-Siris syndrome
inferred← citeshttps://doi.org/10.1016/j.cca.2021.09.015openalex-snapshot
Increase in diagnostic yield achieved for 174 whole-exome sequencing cases reanalyzed 1–2 years after initial analysis
inferred← citeshttps://doi.org/10.1016/j.cca.2024.117795openalex-snapshot
Whole exome sequencing approach for identification of the molecular etiology in pediatric patients with hematuria
inferred← citeshttps://doi.org/10.1016/j.cell.2019.02.040openalex-snapshot
A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers
inferred← citeshttps://doi.org/10.1016/j.clim.2024.110375openalex-snapshot
Clinical exome sequencing data from patients with inborn errors of immunity: Cohort level diagnostic yield and the benefit of systematic reanalysis
inferred← citeshttps://doi.org/10.1016/j.ebiom.2020.102784openalex-snapshot
Genetics of mitochondrial diseases: Identifying mutations to help diagnosis
inferred← citeshttps://doi.org/10.1016/j.ecl.2017.01.015openalex-snapshot
Genetics of Disorders of Sex Development
inferred← citeshttps://doi.org/10.1016/j.ejmg.2017.07.003openalex-snapshot
Pierpont syndrome associated with the p.Tyr446Cys missense mutation in TBL1XR1
inferred← citeshttps://doi.org/10.1016/j.ejmg.2018.04.016openalex-snapshot
Underdiagnoses resulting from variant misinterpretation: Time for systematic reanalysis of whole exome data?
inferred← citeshttps://doi.org/10.1016/j.ejmg.2022.104570openalex-snapshot
Genetic causes of rare and common epilepsies: What should the epileptologist know?
inferred← citeshttps://doi.org/10.1016/j.ejmg.2023.104774openalex-snapshot
Phenotypic specificity in patients with neurodevelopmental delay does not correlate with diagnostic yield of trio-exome sequencing
inferred← citeshttps://doi.org/10.1016/j.eplepsyres.2024.107341openalex-snapshot
Genetic variant interpretation for the neurologist – A pragmatic approach in the next-generation sequencing era in childhood epilepsy
inferred← citeshttps://doi.org/10.1016/j.exer.2024.110109openalex-snapshot
Trio-based whole-exome sequencing of 200 Chinese patients with keratoconus
inferred← citeshttps://doi.org/10.1016/j.gde.2020.05.003openalex-snapshot
The frontiers of sequencing in undiagnosed neurodevelopmental diseases
inferred← citeshttps://doi.org/10.1016/j.gene.2019.03.037openalex-snapshot
Reanalysis of whole exome sequencing data in patients with epilepsy and intellectual disability/mental retardation
inferred← citeshttps://doi.org/10.1016/j.gim.2021.09.007openalex-snapshot
Artificial intelligence (AI)-assisted exome reanalysis greatly aids in the identification of new positive cases and reduces analysis time in a clinical diagnostic laboratory
inferred← citeshttps://doi.org/10.1016/j.gim.2021.09.015openalex-snapshot
The importance of automation in genetic diagnosis: Lessons from analyzing an inherited retinal degeneration cohort with the Mendelian Analysis Toolkit (MATK)
inferred← citeshttps://doi.org/10.1016/j.gim.2021.11.021openalex-snapshot
Automated reanalysis application to assist in detecting novel gene–disease associations after genome sequencing
inferred← citeshttps://doi.org/10.1016/j.gim.2021.12.011openalex-snapshot
Re-analysis of genomic data: An overview of the mechanisms and complexities of clinical adoption
inferred← citeshttps://doi.org/10.1016/j.gim.2022.04.021openalex-snapshot
Recommendations for next generation sequencing data reanalysis of unsolved cases with suspected Mendelian disorders: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.gim.2022.12.001openalex-snapshot
A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network
inferred← citeshttps://doi.org/10.1016/j.gim.2023.100018openalex-snapshot
A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing
inferred← citeshttps://doi.org/10.1016/j.gim.2023.100830openalex-snapshot
Evaluation of an automated genome interpretation model for rare disease routinely used in a clinical genetic laboratory
inferred← citeshttps://doi.org/10.1016/j.gim.2024.101115openalex-snapshot
Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis
inferred← citeshttps://doi.org/10.1016/j.gim.2024.101199openalex-snapshot
Considerations for reporting variants in novel candidate genes identified during clinical genomic testing
inferred← citeshttps://doi.org/10.1016/j.gim.2024.101276openalex-snapshot
Evaluation of Bayesian point-based system on the variant classification of hereditary cancer predisposition genes
inferred← citeshttps://doi.org/10.1016/j.gim.2025.101403openalex-snapshot
Long-term follow-up of children who received rapid genomic sequencing
inferred← citeshttps://doi.org/10.1016/j.gim.2025.101464openalex-snapshot
Impact of laboratory-driven proactive reanalysis: Reclassification to positive in 5% of initially negative or uncertain exome sequencing cases
inferred← citeshttps://doi.org/10.1016/j.gim.2025.101576openalex-snapshot
Ten years of exome sequencing and reanalysis among racial, ethnic, and ancestral groups: The importance of equitable reanalysis access
inferred← citeshttps://doi.org/10.1016/j.gim.2025.101626openalex-snapshot
Increased yield of genetic diagnoses in inherited heart diseases using expanded genome and RNA-splicing analyses
inferred← citeshttps://doi.org/10.1016/j.gimo.2023.100820openalex-snapshot
Evolution of virtual gene panels over time and implications for genomic data re-analysis
inferred← citeshttps://doi.org/10.1016/j.gimo.2025.103442openalex-snapshot
Framework for standardized genetic testing recommendations for chronic kidney disease in Ontario
inferred← citeshttps://doi.org/10.1016/j.gimo.2026.104488openalex-snapshot
Artificial intelligence-assisted clinical exome sequencing: Insights and outcomes from 822 pediatric diagnoses
inferred← citeshttps://doi.org/10.1016/j.jmoldx.2018.07.008openalex-snapshot
Automated Clinical Exome Reanalysis Reveals Novel Diagnoses
inferred← citeshttps://doi.org/10.1016/j.jmoldx.2021.11.004openalex-snapshot
A Framework of Critical Considerations in Clinical Exome Reanalyses by Clinical and Laboratory Standards Institute
inferred← citeshttps://doi.org/10.1016/j.jmoldx.2021.12.002openalex-snapshot
Molecular Diagnostic Outcomes from 700 Cases
inferred← citeshttps://doi.org/10.1016/j.jmoldx.2022.02.003openalex-snapshot
Systematic Collaborative Reanalysis of Genomic Data Improves Diagnostic Yield in Neurologic Rare Diseases
inferred← citeshttps://doi.org/10.1016/j.kint.2020.02.028openalex-snapshot
Machine learning, the kidney, and genotype–phenotype analysis
inferred← citeshttps://doi.org/10.1016/j.kint.2020.03.031openalex-snapshot
Genetic testing for kidney disease of unknown etiology
inferred← citeshttps://doi.org/10.1016/j.kint.2026.02.033openalex-snapshot
Genetic testing in kidney transplantation and living kidney donor risk assessment
inferred← citeshttps://doi.org/10.1016/j.mce.2018.04.003openalex-snapshot
New technologies to uncover the molecular basis of disorders of sex development
inferred← citeshttps://doi.org/10.1016/j.mrrev.2022.108428openalex-snapshot
The contribution of whole-exome sequencing to intellectual disability diagnosis and knowledge of underlying molecular mechanisms: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2024.107010openalex-snapshot
Genome sequencing reanalysis increases the diagnostic yield in dystonia
inferred← citeshttps://doi.org/10.1016/j.pediatrneurol.2023.11.017openalex-snapshot
“Hole” Exome Sequences: The Importance of Phenotyping to Fill the Gaps in Whole Exome Sequencing
inferred← citeshttps://doi.org/10.1016/j.pediatrneurol.2024.09.009openalex-snapshot
A Retrospective Review of Reclassification of Variants of Uncertain Significance in a Pediatric Epilepsy Cohort Undergoing Genetic Panel Testing
inferred← citeshttps://doi.org/10.1016/j.rare.2025.100102openalex-snapshot
A first large study of whole-exome sequencing (WES) in 489 patients with suspected rare genetic disorders at a tertiary centre in Malaysia
inferred← citeshttps://doi.org/10.1016/j.xhgg.2021.100035openalex-snapshot
A data-driven architecture using natural language processing to improve phenotyping efficiency and accelerate genetic diagnoses of rare disorders
inferred← citeshttps://doi.org/10.1016/j.xhgg.2022.100108openalex-snapshot
Genome-wide sequencing and the clinical diagnosis of genetic disease: The CAUSES study
inferred← citeshttps://doi.org/10.1016/j.xhgg.2026.100582openalex-snapshot
Scaling genomic reanalysis to unlock diagnoses and transform rare disease care
inferred← citeshttps://doi.org/10.1016/j.yamp.2021.07.001openalex-snapshot
Current Tools, Databases, and Resources for Phenotype and Variant Analysis of Clinical Exome Sequencing
inferred← citeshttps://doi.org/10.1016/j.yebeh.2019.06.017openalex-snapshot
What is the role of next generation sequencing in status epilepticus?
inferred← citeshttps://doi.org/10.1016/j.ymgmr.2026.101339openalex-snapshot
Diagnostic yield and variant spectrum of whole-exome sequencing in Iranian probands with congenital and early-onset ocular disorders
inferred← citeshttps://doi.org/10.1017/thg.2023.14openalex-snapshot
Re-evaluation of Genetic Variants in Parkinson’s Disease Using Targeted Panel and Next-Generation Sequencing
inferred← citeshttps://doi.org/10.1038/gim.2017.119openalex-snapshot
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
inferred← citeshttps://doi.org/10.1038/gim.2017.128openalex-snapshot
Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases
inferred← citeshttps://doi.org/10.1038/gim.2017.153openalex-snapshot
Novel findings with reassessment of exome data: implications for validation testing and interpretation of genomic data
inferred← citeshttps://doi.org/10.1038/gim.2017.162openalex-snapshot
Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis
inferred← citeshttps://doi.org/10.1038/gim.2017.246openalex-snapshot
Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders
inferred← citeshttps://doi.org/10.1038/gim.2017.50openalex-snapshot
Assessment of the ExAC data set for the presence of individuals with pathogenic genotypes implicated in severe Mendelian pediatric disorders
inferred← citeshttps://doi.org/10.1038/gim.2018.39openalex-snapshot
Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders
inferred← citeshttps://doi.org/10.1038/nrneph.2017.167openalex-snapshot
Genomic medicine for kidney disease
inferred← citeshttps://doi.org/10.1038/s10038-025-01348-8openalex-snapshot
Reclassification of variants of uncertain significance in neonatal genetic diseases: implications from a clinician’s perspective
inferred← citeshttps://doi.org/10.1038/s41390-019-0597-zopenalex-snapshot
A pediatric perspective on genomics and prevention in the twenty-first century
inferred← citeshttps://doi.org/10.1038/s41431-018-0099-1openalex-snapshot
Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders
inferred← citeshttps://doi.org/10.1038/s41431-018-0114-6openalex-snapshot
Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testing
inferred← citeshttps://doi.org/10.1038/s41431-018-0239-7openalex-snapshot
Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms
inferred← citeshttps://doi.org/10.1038/s41431-018-0328-7openalex-snapshot
Rapid and accurate interpretation of clinical exomes using Phenoxome: a computational phenotype-driven approach
inferred← citeshttps://doi.org/10.1038/s41431-019-0401-xopenalex-snapshot
Unique bioinformatic approach and comprehensive reanalysis improve diagnostic yield of clinical exomes
inferred← citeshttps://doi.org/10.1038/s41431-019-0442-1openalex-snapshot
Increased diagnostic and new genes identification outcome using research reanalysis of singleton exome sequencing
inferred← citeshttps://doi.org/10.1038/s41431-019-0471-9openalex-snapshot
A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis
inferred← citeshttps://doi.org/10.1038/s41431-021-00852-7openalex-snapshot
Solving patients with rare diseases through programmatic reanalysis of genome-phenome data
inferred← citeshttps://doi.org/10.1038/s41431-022-01087-wopenalex-snapshot
Trio-based exome sequencing reveals a high rate of the de novo variants in intellectual disability
inferred← citeshttps://doi.org/10.1038/s41431-023-01291-2openalex-snapshot
Reanalysis of clinical exome identifies the second variant in two individuals with recessive disorders
inferred← citeshttps://doi.org/10.1038/s41431-023-01425-6openalex-snapshot
Re-evaluation and re-analysis of 152 research exomes five years after the initial report reveals clinically relevant changes in 18%
inferred← citeshttps://doi.org/10.1038/s41431-023-01529-zopenalex-snapshot
Systematic reanalysis of genomic data by diagnostic laboratories: a scoping review of ethical, economic, legal and (psycho)social implications
inferred← citeshttps://doi.org/10.1038/s41431-023-01532-4openalex-snapshot
Reanalysis of genomic data, how do we do it now and what if we automate it? A qualitative study
inferred← citeshttps://doi.org/10.1038/s41431-024-01633-8openalex-snapshot
Reanalysis of genomic data in rare disease: current practice and attitudes among Australian clinical and laboratory genetics services
inferred← citeshttps://doi.org/10.1038/s41436-018-0006-8openalex-snapshot
Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness
inferred← citeshttps://doi.org/10.1038/s41436-018-0044-2openalex-snapshot
A comprehensive iterative approach is highly effective in diagnosing individuals who are exome negative
inferred← citeshttps://doi.org/10.1038/s41436-018-0072-yopenalex-snapshot
Phrank measures phenotype sets similarity to greatly improve Mendelian diagnostic disease prioritization
inferred← citeshttps://doi.org/10.1038/s41436-018-0100-yopenalex-snapshot
Navigating the nuances of clinical sequence variant interpretation in Mendelian disease
inferred← citeshttps://doi.org/10.1038/s41436-018-0319-7openalex-snapshot
Pitfalls of clinical exome and gene panel testing: alternative transcripts
inferred← citeshttps://doi.org/10.1038/s41436-018-0343-7openalex-snapshot
Improved diagnostics by exome sequencing following raw data reevaluation by clinical geneticists involved in the medical care of the individuals tested
inferred← citeshttps://doi.org/10.1038/s41436-018-0381-1openalex-snapshot
ClinPhen extracts and prioritizes patient phenotypes directly from medical records to expedite genetic disease diagnosis
inferred← citeshttps://doi.org/10.1038/s41436-019-0473-6openalex-snapshot
De novo and biallelic DEAF1 variants cause a phenotypic spectrum
inferred← citeshttps://doi.org/10.1038/s41436-019-0477-2openalex-snapshot
A retrospective review of multiple findings in diagnostic exome sequencing: halF.A.re distinct and halF.A.re overlapping diagnoses
inferred← citeshttps://doi.org/10.1038/s41436-019-0478-1openalex-snapshot
Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG)
inferred← citeshttps://doi.org/10.1038/s41436-019-0554-6openalex-snapshot
Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders
inferred← citeshttps://doi.org/10.1038/s41436-019-0601-3openalex-snapshot
Using the Delphi method to identify clinicians’ perceived importance of pediatric exome sequencing results
inferred← citeshttps://doi.org/10.1038/s41436-019-0643-6openalex-snapshot
AVADA: toward automated pathogenic variant evidence retrieval directly from the full-text literature
inferred← citeshttps://doi.org/10.1038/s41436-019-0679-7openalex-snapshot
Is there a duty to reinterpret genetic data? The ethical dimensions
inferred← citeshttps://doi.org/10.1038/s41436-019-0719-3openalex-snapshot
The case for implementing sustainable routine, population-level genomic reanalysis
inferred← citeshttps://doi.org/10.1038/s41436-020-00984-zopenalex-snapshot
Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science
inferred← citeshttps://doi.org/10.1038/s41436-021-01238-2openalex-snapshot
InpherNet accelerates monogenic disease diagnosis using patients’ candidate genes’ neighbors
inferred← citeshttps://doi.org/10.1038/s41525-020-00140-1openalex-snapshot
Partially automated whole-genome sequencing reanalysis of previously undiagnosed pediatric patients can efficiently yield new diagnoses
inferred← citeshttps://doi.org/10.1038/s41525-020-00144-xopenalex-snapshot
A three-year follow-up study evaluating clinical utility of exome sequencing and diagnostic potential of reanalysis
inferred← citeshttps://doi.org/10.1038/s41525-020-00161-wopenalex-snapshot
A flexible computational pipeline for research analyses of unsolved clinical exome cases
inferred← citeshttps://doi.org/10.1038/s41525-020-0127-2openalex-snapshot
Challenges in returning results in a genomic medicine implementation study: the Return of Actionable Variants Empirical (RAVE) study
inferred← citeshttps://doi.org/10.1038/s41525-021-00188-7openalex-snapshot
Comparison of the diagnostic yield of aCGH and genome-wide sequencing across different neurodevelopmental disorders
inferred← citeshttps://doi.org/10.1038/s41525-021-00278-6openalex-snapshot
An evaluation of pipelines for DNA variant detection can guide a reanalysis protocol to increase the diagnostic ratio of genetic diseases
inferred← citeshttps://doi.org/10.1038/s41525-024-00404-0openalex-snapshot
Rapid genomic sequencing for genetic disease diagnosis and therapy in intensive care units: a review
inferred← citeshttps://doi.org/10.1038/s41581-020-0325-2openalex-snapshot
Rare genetic causes of complex kidney and urological diseases
inferred← citeshttps://doi.org/10.1038/s41586-025-09613-8openalex-snapshot
GREGoR: accelerating genomics for rare diseases
inferred← citeshttps://doi.org/10.1038/s41598-019-53484-9openalex-snapshot
Germline de novo variants in CSNK2B in Chinese patients with epilepsy
inferred← citeshttps://doi.org/10.1038/s41598-024-57976-1openalex-snapshot
Clinically significant changes in genes and variants associated with epilepsy over time: implications for re-analysis
inferred← citeshttps://doi.org/10.1038/s41598-024-79431-xopenalex-snapshot
Trio-whole exome sequencing reveals the importance of de novo variants in children with intellectual disability and developmental delay
inferred← citeshttps://doi.org/10.1055/a-2812-9577openalex-snapshot
Clinical Testing for Genetic Conditions
inferred← citeshttps://doi.org/10.1056/aioa2300009openalex-snapshot
AI-MARRVEL — A Knowledge-Driven AI System for Diagnosing Mendelian Disorders
inferred← citeshttps://doi.org/10.1056/nejmc1812033openalex-snapshot
Reanalysis of Clinical Exome Sequencing Data
inferred← citeshttps://doi.org/10.1080/23294515.2022.2063994openalex-snapshot
Managing Pandora’s Box: Familial Expectations around the Return of (Future) Germline Results
inferred← citeshttps://doi.org/10.1089/pop.2020.0115openalex-snapshot
Genetic Variant Reinterpretation: Economic and Population Health Management Challenges
inferred← citeshttps://doi.org/10.1093/bfgp/elaa009openalex-snapshot
Challenges in the diagnosis and discovery of rare genetic disorders using contemporary sequencing technologies
inferred← citeshttps://doi.org/10.1093/bib/bbad508openalex-snapshot
Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges
inferred← citeshttps://doi.org/10.1093/bioinformatics/btaa641openalex-snapshot
Identifying disease-causing mutations with privacy protection
inferred← citeshttps://doi.org/10.1093/bioinformatics/btac356openalex-snapshot
An automated multi-modal graph-based pipeline for mouse genetic discovery
inferred← citeshttps://doi.org/10.1093/ejendo/lvag013openalex-snapshot
International guideline on genetic testing of children with short stature
inferred← citeshttps://doi.org/10.1093/jalm/jfad062openalex-snapshot
Clinical Utility and Long-Term Feasibility of Exome and Genome Reanalysis: From the Perspectives of a Clinical Laboratory
inferred← citeshttps://doi.org/10.1093/jamia/ocz179openalex-snapshot
Improving the phenotype risk score as a scalable approach to identifying patients with Mendelian disease
inferred← citeshttps://doi.org/10.1093/med-psych/9780197516881.003.0010openalex-snapshot
Autism Spectrum Disorders Versus Genetic Syndromes
inferred← citeshttps://doi.org/10.1093/nar/gkaa794openalex-snapshot
CSVS, a crowdsourcing database of the Spanish population genetic variability
inferred← citeshttps://doi.org/10.1093/pch/pxx152openalex-snapshot
Genome-wide sequencing technologies: A primer for paediatricians
inferred← citeshttps://doi.org/10.1093/qjmed/hcae187openalex-snapshot
Exome sequencing for nonimmune hydrops fetalis and clinical utility of data reanalysis
inferred← citeshttps://doi.org/10.1097/mcd.0000000000000252openalex-snapshot
Expanding the phenotype in autosomal dominant mental retardation-24: a novel variation in DEAF1 gene
inferred← citeshttps://doi.org/10.1097/mop.0000000000000815openalex-snapshot
Clinical utility of genomic sequencing
inferred← citeshttps://doi.org/10.1097/mph.0000000000002839openalex-snapshot
A Rare Inherited Bone Marrow Failure Syndrome Disclosed by Reanalysis of the Exome Data of a Patient Evaluated for Cytopenia and Dysmorphic Features
inferred← citeshttps://doi.org/10.1097/wco.0000000000000478openalex-snapshot
The rapid evolution of molecular genetic diagnostics in neuromuscular diseases
inferred← citeshttps://doi.org/10.1101/171322openalex-snapshot
AMELIE accelerates Mendelian patient diagnosis directly from the primary literature
inferred← citeshttps://doi.org/10.1101/2020.12.29.20248974openalex-snapshot
AMELIE 3: Fully Automated Mendelian Patient Reanalysis at Under 1 Alert per Patient per Year
inferred← citeshttps://doi.org/10.1101/2022.05.06.22274688openalex-snapshot
Automated Prioritization of Sick Newborns for Whole Genome Sequencing Using Clinical Natural Language Processing and Machine Learning
inferred← citeshttps://doi.org/10.1101/2024.06.14.24308832openalex-snapshot
Clinical exome sequencing data from patients with inborn errors of immunity: cohort level meta-analysis and the benefit of systematic reanalysis
inferred← citeshttps://doi.org/10.1101/2024.12.20.24319228openalex-snapshot
Evaluating Genome Sequencing Strategies: Trio, Singleton, and Standard Testing in Rare Disease Diagnosis
inferred← citeshttps://doi.org/10.1101/2025.11.05.25339593openalex-snapshot
Molecular Epidemiology and Variant Spectrum of Rare Genetic Diseases in the Punjabi Population: A Genomic Perspective from South Asia
inferred← citeshttps://doi.org/10.1101/275479openalex-snapshot
Rapid and Accurate Interpretation of Clinical Exomes Using Phenoxome: a Computational Phenotype-driven Approach
inferred← citeshttps://doi.org/10.1101/461269openalex-snapshot
AVADA Enables Automated Genetic Variant Curation Directly from the Full Text Literature
inferred← citeshttps://doi.org/10.1101/746230openalex-snapshot
Keeping patient phenotypes and genotypes private while seeking disease diagnoses
inferred← citeshttps://doi.org/10.1101/cshperspect.a036533openalex-snapshot
Genetic Counseling in Neurodevelopmental Disorders
inferred← citeshttps://doi.org/10.1101/cshperspect.a036632openalex-snapshot
Genetic Counseling and Genome Sequencing in Pediatric Rare Disease
showing the first 200 of 334 · page through all 334
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.